IL1B and chondrosarcoma: Yang et al. [157] established an in vitro model of OA by inducing SW1353 (human chondrosarcoma cells) with IL-1β and observed that IL-35 suppressed the release of the proangiogenic factor Ang2 in SW1353 cells through the P38 MAPK signaling pathway [157].